ST. LOUIS, Jan. 31, 2014 /PRNewswire/ --Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology company, announced they will be presenting at the following investor conferences in February:
- Leerink Swann Global Healthcare Conference 2014 on Thursday, February 13, 2014 in New York City, presenting at 1:50 PM (Eastern).
- 2014 Citi Global Healthcare Conference on Tuesday, February 25, 2014 in New York City, presenting at 1:00 PM (Eastern).
Interested parties may listen via live audio broadcast and view the presentation slides over the Internet at http://investor.sigmaaldrich.com/. Users can click the "Webcast" icon to access the files.
About Sigma-Aldrich: Sigma-Aldrich, a leading Life Science and High Technology company focused on enhancing human health and safety, manufactures and distributes more than 200,000 chemicals, biochemicals and other essential products to more than 1.4 million customers globally in research and applied labs as well as in industrial and commercial markets. With three distinct business units - Research, Applied and SAFC Commercial - Sigma-Aldrich is committed to enabling science to improve the quality of life. The Company operates in 37 countries, has more than 9,000 employees worldwide and had sales of $2.6 billion in 2012. For more information about Sigma-Aldrich, please visit its website at www.sigma-aldrich.com.
Sigma-Aldrich is a registered trademark of Sigma-Aldrich Co. LLC.
SOURCE Sigma-Aldrich Corporation
